Executive leadership panel

The next phase of growth in biopharma will be determined not simply by scientific innovation, but by the strategic decisions leaders make about portfolio strategy, capital deployment and partnerships.  

During Jefferies, ZS is hosting an invitation-only executive discussion featuring a panel of leaders from biotech, pharma and the investment community. The conversation will explore how organizations are evaluating growth opportunities, navigating uncertainty and making decisions that will shape the next generation of industry leaders.  

Featured speakers

• Susanne Schaffert, Ph.D., former President of Novartis Oncology and current board member, BioNTech, ARTBIO, Vetter Pharma and Novo Holdings  
• Annemarie Hanekamp, Chief Commercial Officer, BioNTech  
• Frank Tang, Managing Director of Healthcare Investment Banking, Morgan Stanley  
• Helen Ho, Chief Business and Strategy Officer, Parabilis Medicines 

Attendance is limited and registration requests are subject to approval.